Aberrant overexpression of ALK has been found in various cancers, including anaplastic large-cell lymphoma,2 non–small cell lung cancer (NSCLC),3 neuroblastoma,4 renal cell carcinoma,5,6 breast cancer,3 and thyroid cancer.7 Here, ALK is linked to neuroblastoma.